Plasma uricase activity and plasma uric acid concentrat | Open-i
Uricase Modified Au/Ni/PANI Microrockets to Reduce Uric Acid Level | Catalysis Letters
![PDF] A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/41089ef858e1e35042f1b1ad8aa3023686e05919/14-Figure9-1.png "PDF] A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties | Semantic Scholar")
PDF] A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties | Semantic Scholar
Enhancing the Response Rate to Recombinant Uricases in Patients with Gout | BioDrugs
WO2003011211A2 - Peg-modified uricase - Google Patents
Molecular models of uricase tetramer (A – C) and of PEG-uricase... | Download Scientific Diagram
Zwitterionic Nanocages Overcome the Efficacy Loss of Biologic Drugs
Engineering polynorbornene based uricase conjugates for gout therapy - American Chemical Society
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia | Nature Communications
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout | Arthritis Research & Therapy | Full Text
PEG antibodies do not cross‐react with uricase‐POEGMA. The reactivity... | Download Scientific Diagram
PEG Uricase: Long Acting Agent for Treating Gout | Biopharma PEG
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase | Arthritis Research & Therapy
RT @Janetbirdope: Cool way to get peg uricase tolerated in #gout. ##Rapamycin nanoparticle Rx w SEL 212 a uricase -infus | RheumNow
Uricase Therapy of Gout | Musculoskeletal Key
A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties | PLOS ONE
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase | Arthritis Research & Therapy
PEGylation: definition, principles, methods and benefits
Zwitterionic Nanocages Overcome the Efficacy Loss of Biologic Drugs | UW Bioengineering
In-silico epitope identification and design of Uricase mutein with reduced immunogenicity - ScienceDirect
Hyperuricemia and Gout: New Clinical Insights and Emerging Treatments
File:PegUricase.png - Wikipedia
Effect of treatment with PEG-uricase on the development of diabetes... | Download Scientific Diagram
Hyperuricemia and Gout: New Clinical Insights and Emerging Treatments
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase | Arthritis Research & Therapy
